TrialSiteNews

Join The Conversation! | https://trialsitenews.com/ Dr. Dan Mishmar and PhD candidate Hadar Medini discuss their recent research on the mitochondria and COVID-19. Is COVID-19 more of a mitochondria dysfunction than a respiratory disease? This interview is based on their peer-reviewed, published paper: Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis. Link | https://www.sciencedirect.com/science/article/pii/S2589004221014425 Dr. Mishmar, a professor, geneticist and evolutionist, runs his own lab (Mishmar Lab) at Ben-Gurion University in Israel. Link | https://lifewp.bgu.ac.il/wp/dmishmar/

What makes Geert Vanden Bossche make statements about the current corona crisis? Does he have the right to speak? What is his background?

Suppose you've had your 2 doses of vaccines. Those clearly don't stop the SARS-CoV-2 virus. So what should you do? An additional booster? Do you get a different effect with more of the same? And is a specific omicron booster a good idea? Geert Vanden Bossche, virologist and vaccinologist, provides clarification and advice.

Voice For Science And Solidarity Interview with Dr. Geert Vanden Bossche Part 1 | Dr. Geert Weighs In On The Question Should We Vaccinate Children? As a parent you are faced with an important but oh so difficult choice, namely whether or not to vaccinate your child. And what is the right thing to do? Geert Vanden Bossche, virologist and vaccinologist, provides clarification and advice.

Join The Conversation! | https://trialsitenews.com/ Dr. David Ostrov PhD is an immunologist at the University of Florida who works in the pathology laboratories. His research team focuses on structure-based drug design to discover novel therapies for preventing and treating diseases. He's recently done research on how repurposed drugs and cheap drug combinations might prevent and/or treat COVID-19. You can learn more about his work and contact him through his lab here: Link | https://pathlabs.ufl.edu/about-us/pathologists/experimental-pathology/drug-discovery/david-a-ostrov-phd/

Dr. David Ostrov PhD is an immunologist at the University of Florida who works in the pathology laboratories. His research team focuses on structure-based drug design to discover novel therapies for preventing and treating diseases.He's recently done research on how repurposed drugs and cheap drug combinations can prevent and/or treat COVID-19. You can learn more about his work and contact him through his lab here: https://pathlabs.ufl.edu/about-us/pathologists/experimental-pathology/drug-discovery/david-a-ostrov-phd/

Join The Conversation! | https://trialsitenews.com/ Medable Inc is a leading platform for patient-centered clinical research and just announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials. Dr. Pamela Tenaerts , chief scientific officer and Sanskriti Thakur , chief growth officer, discuss how Medable is innovating the world of decentralized clinical trials.

Join The Conversation! | https://trialsitenews.com/ Medable Inc is a leading platform for patient-centered clinical research and just announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials. Dr. Pamela Tenaerts , chief scientific officer and Sanskriti Thakur , chief growth officer, discuss how Medable is innovating the world of decentralized clinical trials.

TrialSite News presents a riveting episode of CATalyst with Shabnam Palesa Mohamed, and special guests Dr Shankara Chetty and Omar Khan. Find out what priorities are key for health and science in 2022, what could be causing cancer and prions disease post jab, what the real impact of conflicts of interest and censorship are, why Chetty and Khan call for an equitable way to access medicines that benefit people over astronomical profits, and why they believe that 'civil disobedience' is necessary to end the lockdown. Dr Shankara Chetty: Medical Doctor and Biological Scientist with over 30 years experience in Rural and Remote Primary Care. C19 expert physician. (South Africa). Omar Khan: Leadership development consultant developing corporate leaders and facilitators around the world. He is an author, speaker and researcher. (Sri Lanka/USA). Saturday 15 January 2022. #TrialSiteNews #CATalyst #SouthToNorth #HealthMatters

Join The Conversation! | https://trialsitenews.com/ Dr. Robert Louis, Chief of Neurosurgery and the Empower360 Endowed Chair for Skull Base and Minimally Invasive Neurosurgery at Hoag, is a champion for virtual reality and has led the charge on bringing innovative treatment options to Hoag patients. He recently helped open the new Hoag Center for Advanced Visualization and Immersive Therapeutics - or XR Lab for short - where physicians are researching, developing and deploying the newest XR technologies.

“To think we’re going to boost our way out of this- is preposterous.” Dr David Wiseman I had the fortunate opportunity of interviewing Dr David Wiseman, a PhD research Bio scientist, former Johnson & Johnson clinical trial head-researcher and journal peer reviewer. Dr Wiseman with his small but dedicated team have masterfully compiled a series of slides analysing the data from Israel, UK, Denmark and Canada for the Pfizer-BioNTech Covid vaccine comparing vaccine effectiveness of the primary series of vaccination (dose 1 and 2) with the booster. What he revealed in his analysis of the data was highly alarming and raised many red flags of negative vaccine efficacy and its implications- where the vaccines are doing more harm than good.

Dr. Boulware is an infectious disease expert and researcher at the University of Minnesota. He is one of the lead investigators of the COVID-OUT clinical trial which is testing three drugs and combinations of those drugs as early treatment for COVID-19. Links | https://covidout.umn.edu/

Dr. Klausner is an infectious disease expert and epidemiologist. You can read his full bio here: https://keck.usc.edu/faculty-search/jeffrey-klausner/

Join The Conversation! | https://trialsitenews.com/ Dr. Klausner is an infectious disease expert and epidemiologist. You can read his full bio here | https://keck.usc.edu/faculty-search/jeffrey-klausner/

In this must watch edition of CATalyst, Dr David Wiseman ( PhD Research Bioscientist who was one of the top research scientists at Johnson & Johnson) joins Shabnam Palesa Mohamed for a riveting discussion on US VAERS (Vaccine Adverse Events Reporting System) data that the public has a right to know about. During this informative and often shocking interview, we unpack the second expert letter written to the ACIP (Advisory Committee on Immunisation Practices) by Dr Wiseman and Dr Jessica Rose, Dr Josh Guetzkow and Dr Hervé Seligmann. This urgent letter raises critical issues on vaccine safety, and transparency concerns with regards to ACIP meetings:“Given the circumstances of how the December 16 meeting was announced, concerns about opacity are deepened. Like before, the late notice, the late-publication of a docket number, the failure of email notifications, and late posting of presentation slides, require corrective action.” In the second letter to ACIP by these experts, the data-driven views on the vaccines include: a) Contraindications are warranted for all quasi-vaccines, to include other events (thrombosis, myocarditis, etc.). b) Focusing on a small subset of events in one quasi-vaccine is regulatory misdirection. c) There is insufficient guidance on coagulopathies for Janssen and other quasi-vaccines. d) COVID-19 quasi-vaccine in children 5-11 years: Urgent contraindication and re-evaluation of use is warranted. e) ACIP should be discussing ever reduced benefit for greater risk of the quasi-vaccine rollout. f) Attempting to boost our way out of new variants is the immunological equivalent of heroin addiction. g) A full review of the existing EUAs and BLA is warranted - due to greater prevalence of adverse effects, as well as death far exceeding the TTS rate for Janssen, and the death reports for all three Covid-19 quasi-vaccines. Dr Wiseman asks: Why aren't the regulators doing anything about the data being presented? He also answers questions on regulatory misdirection, whether what is going on is scientific fraud, and what a full review of the quasi-vaccines would look like. We also talk about the importance of ethical scientists and industry whistleblowers. Finally, he offers advice to the public about engaging with science to make informed decisions, and going to law makers and media to make your voice heard.

1131 children aged 12–15-years-old were enrolled in Pfizer’s clinical trial of their mRNA based Covid vaccine. Maddie was one of them. Stephanie, her mother, shares Maddie’s heart-wrenching story with Sonia Elijah for Trial Site News.

Dave Hanaman is president of Curavit Clinical Research https://curavitclinicalresearch.com/

Dr. David Wiseman talks about Molnupiravir and FDA Advisory Committee with Dr. Erin

Join The Conversation! | https://trialsitenews.com/ Brad Hunstable, CEO of Linear Labs and West Point Graduate, lost his 12 year old son Hayden to suicide during the pandemic. He describes it as a perfect storm. In this interview, he talks about Hayden, why it happened, his grieving process, advice for parents, advice for the gaming industry and why conversations are so important. Link to Hayden's Corner | https://haydenscorner.org/

In this edition of CATalyst, Shabnam Palesa Mohamed hosts Dr Jackie Stone (Harare, Zimbabwe), Dr EV Rapiti (Cape Town, South Africa) and Dr Nathi Mdladla (Tshwane, South Africa). The doctors share their experiences during Covid-19, the impact of Ivermectin in their countries, the hostility they face when challenging the status quo, and, how the HIV-Aids virus prepared Africa to face C-19 with courage and innovation. Their message to doctors in Africa and globally? Stand up for the doctors’ right to heal patients.

Join The Conversation! | https://trialsitenews.com/ Bill Pepitone is a former NYPD police officer and candidate for NYC mayor. Website | https://pepitonefornyc.com/

Join The Conversation! | https://trialsitenews.com/ Achal Prabhala on Vaccine Equity and the Role of Gov & Pharmaceutical Companies Achal Prabhala is a researcher, writer and coordinator of AccessIBSA which advocates for equal access to medicines. He is also a fellow of the Shuttleworth Foundation in Bangalore, India.

Join The Conversation! | https://trialsitenews.com/ Dr. Vincent Guilamo-Ramos is Dean of the Duke School of Nursing and vice chancellor for nursing affairs, Duke University. He is founder and currently serves as director of Duke's new Center for Latino Adolescent and Family Health. Link to center | https://nursing.duke.edu/news/duson-launches-new-center-focused-latino-adolescent-family-health

Join The Conversation! | https://trialsitenews.com/ Gabriel Nathan is Editor of OC87 Recovery Diaries, suicide prevention advocate, a writer, actor and star of the documentary, A Beautiful Day Tomorrow. A Beautiful Day Tomorrow: Taking Suicide Awareness on the Road – A charming, sweet, human movie about a man and a car, devoted to spreading suicide awareness and prevention everywhere they go. Link | https://abeautifuldaytomorrow.com/

Join The Conversation! | https://trialsitenews.com/ Gabriel Nathan is Editor of OC87 Recovery Diaries, suicide prevention advocate, a writer, actor and star of the documentary, A Beautiful Day Tomorrow. A Beautiful Day Tomorrow: Taking Suicide Awareness on the Road – A charming, sweet, human movie about a man and a car, devoted to spreading suicide awareness and prevention everywhere they go. Link | https://abeautifuldaytomorrow.com/